Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 07TAIPEI2326, TAIWAN PHARMA: LITTLE DOMESTIC SUPPORT FOR PRICE REFORMS

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #07TAIPEI2326.
Reference ID Created Released Classification Origin
07TAIPEI2326 2007-10-15 08:46 2011-08-23 00:00 UNCLASSIFIED American Institute Taiwan, Taipei
VZCZCXRO9358
PP RUEHCN RUEHGH RUEHVC
DE RUEHIN #2326/01 2880846
ZNR UUUUU ZZH
P 150846Z OCT 07
FM AIT TAIPEI
TO RUEHC/SECSTATE WASHDC PRIORITY 7125
INFO RUEHOO/CHINA POSTS COLLECTIVE
RUCPDOC/DEPT OF COMMERCE WASHDC
RUEATRS/DEPT OF TREASURY WASHDC
UNCLAS SECTION 01 OF 03 TAIPEI 002326 
 
SIPDIS 
 
SIPDIS 
 
STATE FOR EAP/TC 
STATE PASS AIT/W, USTR FOR CHRIS WILSON, COMMERCE FOR 4430/ITA/MAC, 
TREASURY FOR OASIA/TTYANG AND HAARSAGER 
 
E.O. 12958: N/A 
TAGS: ETRD ECON TW
SUBJECT: TAIWAN PHARMA: LITTLE DOMESTIC SUPPORT FOR PRICE REFORMS 
 
Reftel: Taipei 2257 
 
Summary 
------- 
 
1.  (SBU) Taiwan implemented its National Health Insurance (NHI) 
system in 1995, and its health-care system comprises six large 
public medical centers, 16 large privately-owned medical centers, 
and 417 regional and district hospitals. U.S. pharmaceutical 
manufacturers' current top reform priorities are changes to the 
Taiwan Bureau of National Health Insurance (BNHI) drug-reimbursement 
system that would require hospitals to use a standard purchasing 
contract for pharmaceuticals, actual transaction pricing (ATP) for 
all drug purchases, and the separation of drug dispensing and 
prescribing (SDP) so that hospitals have less incentive to drive 
down drug prices.  Based on conversations with system stakeholders 
including doctors, hospital administrators, and NGOs, progress on 
each of these changes will likely be difficult because there is 
little domestic constituency for reform.  Because Taiwan has no 
major international drug manufacturers, hospitals that rely heavily 
on profits from BNHI drug reimbursements, and consumers who are 
largely satisfied with the convenience and coverage of the current 
system, there is limited support for change. Progress on reform will 
therefore require continued U.S. engagement with Taiwan authorities 
and other key stakeholders.  End summary. 
 
Doctors Push More Funding... 
---------------------------- 
 
2. (SBU) Taiwan's doctors advocate increased coverage for drugs, 
especially for chronic diseases such as diabetes and cancer.  In a 
recent meeting with econoff, Dr. Delon Wu, top advisor to the 
privately-owned Chang-gung Hospital and a former hospital director, 
said that NHI's budget is too small to sustain the system, and that 
recent increases in premiums and co-payments are not covering rising 
NHI costs, especially for drugs.  In order to maintain a 
comprehensive NHI, Wu believes that premiums must double, noting 
that Korea--whose level of economic development is comparable to 
Taiwan's--charges taxpayers twice as much per month.  Dr. Lai 
Gi-ming, Director of the Office of Collaborative Medical Affairs at 
the National Health Research Institutes (NHRI), recently made the 
same point to econoff, lamenting that Taiwan's six-percent ratio of 
NHI expenditure to GDP compares poorly to Japan's 9.6 percent and 
Korea's 13 percent. 
 
3. (SBU) Chang King-ren, President of the Chinese Oncology Society, 
gave econoff data from his research showing that spending on 
cancer-fighting drugs is only 0.4 percent of BNHI's budget. 
Chang-gung Hospital's Delon Wu agrees, complaining to econoff that 
due to insufficient budgets, BNHI sets limits on payments for drugs 
used to treat cancer, and that since such drugs are usually more 
expensive than other pharmaceuticals and are used over longer 
periods, BNHI under-serves cancer patients.  Both doctors argue that 
BNHI must increase premiums and reduce payments for non-chronic 
drugs in order to spend more on chronic-illness drugs. 
 
...and Patients Agree 
--------------------- 
 
4. (SBU) Patients' rights groups agree with doctors that drug 
spending in Taiwan is too low, and call for increased funding for 
chronic-illness drugs such as those used for cancer and diabetes. 
Formosa Cancer Foundation advisor Dr. Hsieh Ruey-kuen recently told 
econoff many cancer drugs that physicians want to prescribe are not 
covered by the NHI and are therefore paid by patients themselves, a 
practice that is too costly for many patients and forces some to 
seek out cheaper but less effective treatments.  Hsieh, a cancer 
specialist at Mackay Memorial Hospital, provided data from Mackay 
showing that 60 percent of its tumor patients are paying part or all 
of their drug costs, and said his contacts at Taipei Veterans and 
National Taiwan University Hospitals have told him that the rate at 
their hospitals is even higher. 
 
5. (SBU) In an October 4 meeting with econoff, Ly-yun Chang, 
Chairwoman of Taiwan's largest NGO focusing on overall healthcare 
reform, the Taiwan Health Reform Foundation (THRF), said that THRF 
is also pushing for more NHI spending on cancer drugs.  She pointed 
out that instead of allowing doctors to prescribe the most suitable 
treatment for individual cases of cancer, BNHI's reimbursement rules 
require cancer patients to start with so-called "first-level" 
chemotherapy, and if this treatment is not successful, NHI will pay 
for additional, "second-level" chemotherapy, likewise authorizing 
reimbursement for the more intense--and expensive--"third-level" 
treatments if the second-level chemotherapy proves ineffective. 
 
Doctors, Hospitals Don't Support Major Reforms 
--------------------------------------------- -- 
 
TAIPEI 00002326  002 OF 003 
 
 
 
6. (SBU) However, doctors do not support specific reforms to NHI, 
including standard purchasing contracts, SDP, or other changes to 
the price-volume survey (PVS) methodology that BNHI uses to control 
drug reimbursement costs.  Doctors, and the hospitals that employ 
them, are overly-dependent on revenues derived from the difference 
between the lower prices they have negotiated with drug companies 
and the higher amounts that BNHI reimburses for the same drugs--the 
source of the so-called "Black Hole" in Taiwan's pharmaceuticals 
budget.  Hospitals in Taiwan do not disclose how much money they 
make from this gap, but Dr. Chi-chou Liao, Director General of the 
Taiwan Department of Health (DOH) Bureau of Pharmaceutical Affairs 
(BOPA), told econoff that large public and private hospitals in 
Taiwan such as Chang-gung and Taiwan University Hospital make about 
two-thirds of their profits from prescriptions, and the hospitals 
therefore oppose standardizing contracts or instituting ATP--both of 
which would shrink this price gap--as well as SDP, which would take 
away the bulk of their drug business by making patients fill 
prescriptions at non-hospital pharmacies. 
 
7. (SBU) When econoff asked Chang-gung Hospital's Dr. Wu about the 
Black Hole, he agreed that hospitals rely heavily on income from 
drugs, but asserted that the problem is not that hospitals purposely 
generate profits through their pharmacies, but rather the local 
tradition that doctors charge not for visits, but for the drugs they 
prescribe.  Doctors therefore prescribe drugs at almost every visit, 
while at the same time patients expect to be given drugs whenever 
they see a doctor--including for minor conditions like colds. He 
believes that the way to reduce the Black Hole in BNHI drug expenses 
is therefore not standard contracts, SDP, or ATP, but rather 
changing attitudes that encourage over-prescription. 
 
8. (SBU) Even doctors who want to lower BNHI costs by reducing this 
price gap believe that BNHI's recent efforts to require hospitals to 
use standard contracts (reftel) will not be effective, even if 
adopted by all major hospitals.  A local medical contact told us 
that if drug makers use standard contracts to secure more favorable 
prices from hospitals on individual drugs, hospitals will erect 
bureaucratic obstacles to dissuade their doctors from prescribing 
these now less-profitable drugs, a criticism that BOPA's Dr. Liao 
recently echoed to econoff. 
 
Patient Rights Group Agrees on Contracts, Pushes Other Reforms... 
--------------------------------------------- --------- 
 
9. (SBU) THRF Chairwoman Chang also cast doubts on the effectiveness 
of standard contracts.  She said that while THRF does not oppose 
requiring hospitals to use a standard contract, she alleged that 
Taiwan's hospitals commonly keep two books to hide how much they 
actually pay for drugs, and that requiring standardized contracts 
will therefore not force hospitals to reveal their true spending. 
She also reasons that since Taiwan's hospitals have too much market 
power, they will still be able to squeeze drug makers for lower 
prices. Chang said that pushing for standard contracts is not, 
therefore, a priority for the Foundation. 
 
10.  (SBU) THRF does support SDP, however.  Currently, due to 
hospitals' reluctance to release prescriptions to patients as well 
as varying and confusing prescription formats, hospitals effectively 
monopolize drug dispensing.  Chang believes that standardizing 
prescription formats and requiring hospitals to release all 
refillable and chronic-disease prescriptions to patients would both 
encourage patients to use local pharmacies and enable local 
pharmacists to better understand and meet patients' prescription 
needs.  THRF is aware that while some small pharmacies may not be 
able to carry as wide a selection of drugs as large hospitals--and 
likewise won't have the sales volume to enable them to compete on 
price for some drugs--they believe that it is an essential first 
step toward overcoming the Black Hole problem.  Despite hospital 
opposition, Chang is also optimistic that SDP could happen in the 
near future, noting to econoff that while DOH and BNHI officials 
would never "dare" to mention SDP six years ago out of fear of a 
backlash from hospitals, both are starting to explore ways to 
implement at least partial SDP. 
 
11. (SBU) THRF is also pushing for pharmacies to print detailed 
descriptions of prescribed drugs, their effects, and the cost to 
both the patient directly on labels or packaging of prescribed 
pharmaceuticals.  Chang thinks that such labels would be the most 
efficient way to promote both safe drug use and price transparency. 
 
 
...But Has Little Political Influence 
-------------------------------------- 
 
12. (SBU) However, Chang lamented that, compared to Taiwan's various 
doctor and hospital associations, THRF has almost no influence with 
 
TAIPEI 00002326  003 OF 003 
 
 
the Legislative Yuan (LY). She also noted that the general public is 
satisfied with the convenience, coverage, and low out-of-pocket 
costs of the current system.  The average citizen is therefore not 
concerned about drug-pricing issues, and since patients prefer to 
get their drugs directly from the hospital pharmacies, many are not 
in the habit of asking for copies of their prescriptions to use for 
refills at local pharmacies.  According to a THRF survey done in 
2004-2005, 80 percent of patients polled were satisfied with the 
current drug-dispensing situation.  Patients, therefore, are not 
putting pressure on the LY or BNHI to push hospitals to give up 
their drug-dispensing functions. 
 
Comment 
---------- 
13. (SBU) Doctors in Taiwan--and the hospitals that they work 
for--form the most powerful domestic medical interest group, and 
since they do not support the reforms advocated by foreign 
original-drug manufacturers, progress toward such reforms will 
require sustained U.S. engagement with Taiwan authorities and major 
stakeholders.  End comment.